LinkedIn Content Strategy & Writing Style
Director | Commercial Strategy · Business Development · Launch Operations | Rare Disease & Oncology | Biotech & Pharma | US · EMEA · APAC | Fulbright Scholar | PMP
1 person tracking this creator on ViralBrain
Kerem Can Alp positions himself as a high-level geopolitical strategist for the biopharma industry, bridging the gap between commercial operations and macro policy. His content strategy centers on dissecting the "global division of labor," where he moves beyond surface-level news to analyze how trade wars, regulatory shifts, and capital flows redefine drug development. He is notable for his ability to translate complex legislative moves—like the BINSA Act or MFN pricing—into tangible commercial risks and opportunities for biotech leaders. Alp’s work sits at a sophisticated intersection of sovereign infrastructure and market access, frequently exploring how the "industrialization of opacity" in drug pricing and the centralization of AI compute power create new competitive moats or vulnerabilities across the US, Europe, and China.
0
0
31
2
Spain just made drug prices a state secret. MFN killed pricing transparency on both sides of the Atlantic. Spain's Health Commission voted 33–1 to legally prohibit disclosure of the prices it pays fo…
The US just opened a trade investigation into Germany’s drug pricing. The same mechanism used against China. This is not the opening move. MFN, investment withdrawal, and now a formal trade investiga…
Pharma sells drugs to cure or manage diseases. But a growing number of people want to optimize their health and longevity. Not fix what is broken. 𝗧𝗵𝗶𝘀 𝗱𝗲𝗺𝗮𝗻𝗱 𝗵𝗮𝘀 𝘂𝗻𝗹𝗼𝗰𝗸𝗲𝗱 𝗮 𝗺�…
Everyone says AI will reinvent the pharma value chain. So why is 88% of the spending concentrated in R&D? The use cases of AI are everywhere: diagnosis, supply chain, clinical ops, commercialization.…
WSJ frames Chinese biotechs as copycats chasing US innovation, and US biotechs as going dark to stop them. It's a futile strategy, and dodges the real problem. 𝗧𝘄𝗼 𝗱𝗶𝗳𝗳𝗲𝗿𝗲𝗻𝘁 𝗽𝗿𝗼𝗯𝗹𝗲…
While Europe complains that the US extracts its best science, Ipsen's acquisition of Kartos Therapeutics, Inc. proves that a sophisticated global division of labor is at play. In H1 2026, European mi…
2.5 posts/week
Posts / Week
2
Total Posts Analyzed
MEDIUM
Posting Frequency
31.3%
Avg Engagement Rate
STABLE
Performance Trend
350
Avg Length (Words)
HIGH
Depth Level
ADVANCED
Expertise Level
0.92/10
Uniqueness Score
YES
Question Usage
0.85%
Response Rate
Writing style breakdown
<start of post>
The US just signaled the end of the 'Globalized Science' era.
What was once a frictionless exchange of IP is now a matter of national security.
𝗧𝗵𝗲 𝗕𝗜𝗡𝗦𝗔 𝗔𝗰𝘁 𝗶𝘀𝗻'𝘁 𝗷𝘂𝘀𝘁 𝗮 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗵𝘂𝗿𝗱𝗹𝗲. 𝗜𝘁'𝘀 𝗮 𝗯𝗼𝗿𝗱𝗲𝗿 𝗳𝗲𝗻𝗰𝗲.
For a decade, the playbook was simple: discover in the West, develop in the East, and exit on Nasdaq. That loop is being systematically dismantled by two sovereigns moving in lockstep for opposite reasons.
Sign in to unlock the full writing analysis
Free tools to help you write, score, and benchmark in the same style.
Other creators worth studying alongside Kerem Can Alp.
Eric Ries
Author of Incorruptible: Why Good Companies Go Bad...and How Great Companies Stay Great (coming May 26) | NYT Bestselling Author of The Lean Startup | Founder, LTSE
Boyuan Deng
Rank on Google and ChatGPT for organic traffic without manual work @ RankAI (YC S23)
311 Viral Score
Alexander Klöpping
Uitgever van Co-intelligentie en Smartphonevrij Opgroeien
56 Viral Score
Jeroen Disch
Art director & design educator | 20+ years experience in branding & digital design | Author of Halfvet (3,000+ subscribers) | Co-founder of Variable Font Course | Speaker & advisor on AI in design
107 Viral Score
Pieter Zwart
Entrepreneur and CEO Coolblue
94 Viral Score
Ahmed Nasr 🧠
MBA - Marketing Manager | 360 Marketing & Digital Strategy | Creative Product Marketing | PR Specialist | Turning Great Ideas into Greater Results 🚀
32 Viral Score
ViralBrain plans, writes, and schedules your LinkedIn content, using official LinkedIn APIs so your account stays safe.
Write like Kerem Can Alp.
